Skip to content
Late-StageResearch compoundLimited evidence

Phenibut

Anxiety-relieving drug, prescription-only in Russia; can cause severe dependence and life-threatening withdrawal.

AnxiolyticSleep SupportSleep/AnxietyanxiolyticgabaGABAGlutamate

Pharmacology

ClassSleep/Anxiety · anxiolytic · gaba
Primary targetGABA-B receptor agonist
Targets3 receptor targets
EvidenceLimited evidence
Affected systemsGABAGlutamate

Contents

Related comparisons

Phenibut vs F-Phenibut

DETAILED OVERVIEW

What is Phenibut?

Phenibut is an anxiety-relieving substance developed in the Soviet Union. It is a prescription medicine in Russia, Ukraine and Latvia, has been a controlled substance in the United Kingdom since 2024, and is not approved elsewhere in Europe or in the United States. In Hungary it cannot be placed on the market as a medicine without a prescription.

It acts on one of the brain's calming systems, the one run by a messenger called GABA. The evidence for its effects is limited. With regular use, tolerance builds up very quickly and severe physical dependence can develop. After longer use, stopping suddenly can cause life-threatening withdrawal: anxiety, insomnia, tremor, seizures and confusion (delirium). Together with alcohol or other sedatives it can cause deep drowsiness, dangerously slowed breathing and loss of consciousness. It is to be avoided in pregnancy and breastfeeding, because of the risk of dependence and of withdrawal in the baby.

Mechanism

GABA-B agonist + Ca²⁺-α2δ

Half-life

~5 h

Legal status

Russia Rx / UK Class C (2024)

Receptor profile

  • GABA-B receptorStrong
  • Alpha-2-delta calcium channelModerate
  • GABA-A receptorWeak

Safety

Side effects, stop signs, contraindications

Side effects · 7

  • Sedation, drowsiness and fatigue, especially at higher doses
  • Rapid tolerance buildup after just 2-3 days of continuous use
  • Physical dependence and benzodiazepine-like withdrawal syndrome (anxiety, insomnia, tremor, in severe cases seizures, delirium)
  • Rebound anxiety and irritability as the effect wears off
  • Nausea, stomach discomfort, loss of appetite
  • Hangover-like grogginess, impaired concentration and balance during the effect
  • At overdose, deep sedation, respiratory depression, loss of consciousness (especially combined with alcohol or other sedatives)

Contraindications · 6

  • Avoid during pregnancy and breastfeeding (risk of dependence and neonatal withdrawal)
  • Dangerous combined with alcohol, benzodiazepines, opioids and other CNS depressants (additive sedation, respiratory depression)
  • Contraindicated in those with a history of substance use disorder or addiction due to high dependence potential
  • Must not be stopped abruptly after prolonged use, as life-threatening withdrawal may occur; gradual tapering is required
  • Caution in renal impairment (excretion is predominantly renal, risk of accumulation)
  • Avoid driving and operating machinery during the effect due to sedation and slowed reaction time

Related Nootropics

Same therapeutic category

FAQ

FAQ

Phenibut is a strong calming, anti-anxiety compound available on prescription in Russia, acting on one of the brain's own relaxing systems. It was developed mainly to reduce anxiety, and unlike plain GABA it reportedly crosses into the brain more easily, which can make its effect stronger and faster.

Telegram

Have a question about Phenibut?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeAnxiolytic
FormulaC10H13NO2
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.